, Tracking Stock Market Picks
Enter Symbol:

up 279.62 %

MAKO SURGICAL CORP (MAKO) rated Buy with price target $18 by Ladenburg Thalmann

Posted on: Tuesday,  Mar 9, 2010  12:25 PM ET by Ladenburg Thalmann

Ladenburg Thalmann rated Buy MAKO SURGICAL CORP (NASDAQ: MAKO) on 03/09/2010. Previously Ladenburg Thalmann rated Buy MAKO SURGICAL CORP (NASDAQ: MAKO) on
03/11/2009., when the stock price was $7.90. Since then, MAKO SURGICAL CORP has gained 279.62% as of 12/16/2013's recent price of $29.99.
If you would have followed the previous Ladenburg Thalmann's recommendation on MAKO, you would have gained 279.62% of your investment in 1741 days.

MAKO Surgical Corp. (MAKO) is a medical device company that markets its robotic arm solution and orthopedic implants for minimally invasive orthopedic knee procedures. MAKO offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific, early to mid-stage osteoarthritic knee disease. Its robotic arm systems, branded as its first generation Tactile Guidance System (TGS), and its second generation RIO Robotic Arm Interactive Orthopedic system (RIO), utilize tactile guided robotic arm technology and patient specific visualization to prepare the knee joint for the insertion and alignment of its resurfacing implants through a small incision in a minimally invasive, bone preserving and tissue sparing procedure. MAKO has an intellectual property portfolio of more than 250 licensed or owned patents and patent applications relating to the areas of computer assisted surgery, robotics, haptics and implants.

Our Research Department takes a fresh, critical approach to analyzing primary sources and developing proprietary research. Many individuals, institutions, portfolio managers and hedge fund managers, on all levels, have been neglected by brokerage firms ignoring the demands for unbiased research. Ladenburg Thalmann provides a superior branded in-depth research product geared only to action-oriented investment ideas. Ladenburg Thalmann’s proprietary equity research tries to uncover crucial information before the rest of the Street. Our analysts concentrate on uncovered and under-covered stocks and have a small to mid-cap focus. We will not shy away from large cap names as long as we can bring value to our clients through timely, differentiated ideas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/9/2010 12:25 PM Buy
13.96 18.00
as of 12/31/2010
1 Week up  7.69 %
1 Month up  41.49 %
3 Months up  69.41 %
1 YTD up  46.21 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2009 10:25 AM Buy
7.61 10.00
3/11/2009 9:25 AM Buy
7.90 100.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy